fanta.bio Sample: CNhs11249
19725 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1999 / 19217 (10.4%) | 776 / 192170 (0.4%) | −324.0 | −324.0 | 25.76 |
| SCML2 SRX644728 | 293 Kidney | 1778 / 19217 (9.3%) | 696 / 192170 (0.4%) | −324.0 | −324.0 | 25.55 |
| HIF1A SRX11007095 | HK-2 Kidney | 2492 / 19217 (13.0%) | 982 / 192170 (0.5%) | −324.0 | −324.0 | 25.38 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1207 / 19217 (6.3%) | 491 / 192170 (0.3%) | −324.0 | −324.0 | 24.58 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2847 / 19217 (14.8%) | 1160 / 192170 (0.6%) | −324.0 | −324.0 | 24.54 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2741 / 19217 (14.3%) | 1152 / 192170 (0.6%) | −324.0 | −324.0 | 23.79 |
| HIF1A SRX20663235 | HK-2 Kidney | 572 / 19217 (3.0%) | 282 / 192170 (0.1%) | −324.0 | −324.0 | 20.28 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1741 / 19217 (9.1%) | 861 / 192170 (0.4%) | −324.0 | −324.0 | 20.22 |
| FOXP1 SRX736067 | LNCAP Prostate | 2168 / 19217 (11.3%) | 1174 / 192170 (0.6%) | −324.0 | −324.0 | 18.47 |
| TP53 SRX19538279 | Osteoblasts Bone | 544 / 19217 (2.8%) | 328 / 192170 (0.2%) | −324.0 | −324.0 | 16.59 |
| MYH11 SRX265221 | ME-1 Blood | 971 / 19217 (5.1%) | 665 / 192170 (0.3%) | −324.0 | −324.0 | 14.60 |
| MED1 SRX9419945 | BT-474 Breast | 3924 / 19217 (20.4%) | 3054 / 192170 (1.6%) | −324.0 | −324.0 | 12.85 |
| MED1 SRX9419944 | BT-474 Breast | 3798 / 19217 (19.8%) | 3028 / 192170 (1.6%) | −324.0 | −324.0 | 12.54 |
| BRD4 SRX9419935 | BT-474 Breast | 3853 / 19217 (20.0%) | 3104 / 192170 (1.6%) | −324.0 | −324.0 | 12.41 |
| MED1 SRX9419946 | BT-474 Breast | 3965 / 19217 (20.6%) | 3234 / 192170 (1.7%) | −324.0 | −324.0 | 12.26 |
| BRD4 SRX9419936 | BT-474 Breast | 3942 / 19217 (20.5%) | 3225 / 192170 (1.7%) | −324.0 | −324.0 | 12.22 |
| MED1 SRX9419947 | BT-474 Breast | 3835 / 19217 (20.0%) | 3176 / 192170 (1.7%) | −324.0 | −324.0 | 12.07 |
| BRD4 SRX9419937 | BT-474 Breast | 3789 / 19217 (19.7%) | 3153 / 192170 (1.6%) | −324.0 | −324.0 | 12.02 |
| BRD4 SRX9419938 | BT-474 Breast | 3912 / 19217 (20.4%) | 3263 / 192170 (1.7%) | −324.0 | −324.0 | 11.99 |
| EZH2 SRX2146136 | LNCAP Prostate | 9604 / 19217 (50.0%) | 8456 / 192170 (4.4%) | −324.0 | −324.0 | 11.36 |
| BRD4 SRX736201 | 90-8TL Neural | 6695 / 19217 (34.8%) | 7427 / 192170 (3.9%) | −324.0 | −324.0 | 9.01 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2041 / 19217 (10.6%) | 2969 / 192170 (1.5%) | −324.0 | −324.0 | 6.87 |
| PBX4 SRX2731658 | PC-3 Prostate | 1061 / 19217 (5.5%) | 30337 / 192170 (15.8%) | −324.0 | −324.0 | 0.35 |
| FOS SRX150478 | MCF 10A Breast | 746 / 19217 (3.9%) | 23340 / 192170 (12.1%) | −324.0 | −324.0 | 0.32 |
| FOS SRX150477 | MCF 10A Breast | 692 / 19217 (3.6%) | 22748 / 192170 (11.8%) | −324.0 | −324.0 | 0.30 |
| YAP1 SRX757325 | H2052 Lung | 676 / 19217 (3.5%) | 23484 / 192170 (12.2%) | −324.0 | −324.0 | 0.29 |
| YAP1 SRX757326 | H2052 Lung | 603 / 19217 (3.1%) | 20991 / 192170 (10.9%) | −324.0 | −324.0 | 0.29 |
| ESR1 SRX4367193 | MCF-7 Breast | 1054 / 19217 (5.5%) | 27211 / 192170 (14.2%) | −302.9 | −299.8 | 0.39 |
| ESR1 SRX7624157 | MCF-7 Breast | 825 / 19217 (4.3%) | 23634 / 192170 (12.3%) | −299.0 | −296.0 | 0.35 |
| TP53 SRX19538274 | U2OS Bone | 441 / 19217 (2.3%) | 203 / 192170 (0.1%) | −296.6 | −293.6 | 21.72 |
| TP53 SRX19538268 | U2OS Bone | 437 / 19217 (2.3%) | 200 / 192170 (0.1%) | −294.5 | −291.4 | 21.85 |
| ESR1 SRX20282961 | MCF-7 Breast | 358 / 19217 (1.9%) | 15654 / 192170 (8.1%) | −293.3 | −290.3 | 0.23 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 733 / 19217 (3.8%) | 1043 / 192170 (0.5%) | −289.5 | −286.5 | 7.03 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 770 / 19217 (4.0%) | 22374 / 192170 (11.6%) | −286.9 | −283.9 | 0.34 |
| SS18 SRX3468047 | Fibroblasts Others | 816 / 19217 (4.2%) | 23049 / 192170 (12.0%) | −285.7 | −282.7 | 0.35 |
| FOS SRX4192880 | MCF 10A Breast | 540 / 19217 (2.8%) | 18495 / 192170 (9.6%) | −281.7 | −278.7 | 0.29 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 443 / 19217 (2.3%) | 246 / 192170 (0.1%) | −279.8 | −276.8 | 18.01 |
| TP53 SRX19538276 | U2OS Bone | 428 / 19217 (2.2%) | 217 / 192170 (0.1%) | −279.0 | −276.0 | 19.72 |
| ESR1 SRX371478 | MCF-7 Breast | 395 / 19217 (2.1%) | 15858 / 192170 (8.3%) | −277.5 | −274.5 | 0.25 |
| TP53 SRX19538267 | U2OS Bone | 401 / 19217 (2.1%) | 175 / 192170 (0.1%) | −274.2 | −271.3 | 22.91 |
| ESR1 SRX7624156 | MCF-7 Breast | 512 / 19217 (2.7%) | 17792 / 192170 (9.3%) | −274.1 | −271.2 | 0.29 |
| ESR1 SRX20282960 | MCF-7 Breast | 339 / 19217 (1.8%) | 14728 / 192170 (7.7%) | −273.8 | −270.9 | 0.23 |
| Epitope tags SRX5877912 | U2OS Bone | 2061 / 19217 (10.7%) | 39828 / 192170 (20.7%) | −273.6 | −270.7 | 0.52 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 743 / 19217 (3.9%) | 21466 / 192170 (11.2%) | −272.2 | −269.3 | 0.35 |
| TP53 SRX19538280 | Osteoblasts Bone | 432 / 19217 (2.2%) | 242 / 192170 (0.1%) | −272.0 | −269.1 | 17.85 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 720 / 19217 (3.7%) | 1093 / 192170 (0.6%) | −271.6 | −268.7 | 6.59 |
| ESR1 SRX371469 | MCF-7 Breast | 312 / 19217 (1.6%) | 14060 / 192170 (7.3%) | −268.2 | −265.4 | 0.22 |
| ESR1 SRX176860 | MCF-7 Breast | 539 / 19217 (2.8%) | 17997 / 192170 (9.4%) | −266.3 | −263.5 | 0.30 |
| TP53 SRX19538275 | U2OS Bone | 398 / 19217 (2.1%) | 187 / 192170 (0.1%) | −265.9 | −263.1 | 21.28 |
| ESR1 SRX371479 | MCF-7 Breast | 270 / 19217 (1.4%) | 13179 / 192170 (6.9%) | −265.4 | −262.6 | 0.20 |
| ESR1 SRX20282939 | MCF-7 Breast | 350 / 19217 (1.8%) | 14644 / 192170 (7.6%) | −264.1 | −261.3 | 0.24 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1193 / 19217 (6.2%) | 27720 / 192170 (14.4%) | −261.3 | −258.5 | 0.43 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 714 / 19217 (3.7%) | 20625 / 192170 (10.7%) | −260.7 | −257.9 | 0.35 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 838 / 19217 (4.4%) | 22496 / 192170 (11.7%) | −259.7 | −256.9 | 0.37 |
| ESR1 SRX20282972 | MCF-7 Breast | 344 / 19217 (1.8%) | 14396 / 192170 (7.5%) | −259.4 | −256.6 | 0.24 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1201 / 19217 (6.2%) | 27742 / 192170 (14.4%) | −258.8 | −256.0 | 0.43 |
| TP53 SRX19538273 | U2OS Bone | 384 / 19217 (2.0%) | 180 / 192170 (0.1%) | −256.8 | −254.0 | 21.33 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1192 / 19217 (6.2%) | 27519 / 192170 (14.3%) | −256.2 | −253.5 | 0.43 |
| GATA3 SRX190239 | MCF-7 Breast | 492 / 19217 (2.6%) | 16856 / 192170 (8.8%) | −255.2 | −252.4 | 0.29 |
| FOS SRX150517 | MCF 10A Breast | 593 / 19217 (3.1%) | 18503 / 192170 (9.6%) | −254.6 | −251.8 | 0.32 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1301 / 19217 (6.8%) | 28966 / 192170 (15.1%) | −254.2 | −251.5 | 0.45 |
| ESR1 SRX176861 | MCF-7 Breast | 562 / 19217 (2.9%) | 17985 / 192170 (9.4%) | −254.2 | −251.5 | 0.31 |
| JUN SRX17561461 | LPS141 Adipocyte | 472 / 19217 (2.5%) | 16485 / 192170 (8.6%) | −254.1 | −251.4 | 0.29 |
| AGO2 SRX4708039 | Hep G2 Liver | 2063 / 19217 (10.7%) | 8487 / 192170 (4.4%) | −253.4 | −250.7 | 2.43 |
| JUNB SRX8488088 | SUM 229PE Breast | 664 / 19217 (3.5%) | 19588 / 192170 (10.2%) | −253.1 | −250.4 | 0.34 |
| TP53 SRX19538281 | Osteoblasts Bone | 454 / 19217 (2.4%) | 346 / 192170 (0.2%) | −252.8 | −250.1 | 13.12 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 825 / 19217 (4.3%) | 22052 / 192170 (11.5%) | −252.6 | −249.9 | 0.37 |
| FOXA1 SRX176862 | MCF-7 Breast | 447 / 19217 (2.3%) | 16004 / 192170 (8.3%) | −252.4 | −249.7 | 0.28 |
| AR SRX1067071 | LHSAR Prostate | 686 / 19217 (3.6%) | 19885 / 192170 (10.3%) | −251.6 | −248.9 | 0.34 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1408 / 19217 (7.3%) | 30331 / 192170 (15.8%) | −251.6 | −248.9 | 0.46 |
| Epitope tags SRX5877914 | U2OS Bone | 2114 / 19217 (11.0%) | 39568 / 192170 (20.6%) | −251.2 | −248.6 | 0.53 |
| ESR1 SRX1531791 | MCF-7 Breast | 300 / 19217 (1.6%) | 13335 / 192170 (6.9%) | −251.0 | −248.3 | 0.22 |
| ESR1 SRX20282954 | MCF-7 Breast | 353 / 19217 (1.8%) | 14226 / 192170 (7.4%) | −248.2 | −245.5 | 0.25 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 674 / 19217 (3.5%) | 19568 / 192170 (10.2%) | −247.9 | −245.3 | 0.34 |
| ESR1 SRX371467 | MCF-7 Breast | 340 / 19217 (1.8%) | 13975 / 192170 (7.3%) | −247.8 | −245.2 | 0.24 |
| AR SRX1067070 | LHSAR Prostate | 878 / 19217 (4.6%) | 22616 / 192170 (11.8%) | −246.1 | −243.5 | 0.39 |
| ESR1 SRX194569 | MCF-7 Breast | 341 / 19217 (1.8%) | 13942 / 192170 (7.3%) | −246.0 | −243.4 | 0.24 |
| ESR1 SRX20282973 | MCF-7 Breast | 395 / 19217 (2.1%) | 14905 / 192170 (7.8%) | −246.0 | −243.3 | 0.27 |
| SMARCA2 SRX8119677 | MeT-5A Others | 551 / 19217 (2.9%) | 17515 / 192170 (9.1%) | −245.2 | −242.6 | 0.31 |
| SMARCA4 SRX5212362 | Mel270 Others | 596 / 19217 (3.1%) | 18221 / 192170 (9.5%) | −244.6 | −242.0 | 0.33 |
| FOXA1 SRX176863 | MCF-7 Breast | 416 / 19217 (2.2%) | 15222 / 192170 (7.9%) | −244.5 | −241.9 | 0.27 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1044 / 19217 (5.4%) | 24979 / 192170 (13.0%) | −244.4 | −241.8 | 0.42 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 391 / 19217 (2.0%) | 14771 / 192170 (7.7%) | −244.1 | −241.5 | 0.26 |
| FOXA1 SRX4815197 | MCF-7 Breast | 892 / 19217 (4.6%) | 22748 / 192170 (11.8%) | −244.0 | −241.4 | 0.39 |
| GATA3 SRX190194 | SK-N-SH Neural | 847 / 19217 (4.4%) | 22080 / 192170 (11.5%) | −244.0 | −241.4 | 0.38 |
| ESR1 SRX4367192 | MCF-7 Breast | 728 / 19217 (3.8%) | 20194 / 192170 (10.5%) | −241.7 | −239.1 | 0.36 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 403 / 19217 (2.1%) | 14856 / 192170 (7.7%) | −239.9 | −237.3 | 0.27 |
| ESR1 SRX10365535 | MCF-7 Breast | 247 / 19217 (1.3%) | 11963 / 192170 (6.2%) | −238.7 | −236.1 | 0.21 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1332 / 19217 (6.9%) | 4292 / 192170 (2.2%) | −238.2 | −235.6 | 3.10 |
| ESR1 SRX20282940 | MCF-7 Breast | 360 / 19217 (1.9%) | 14027 / 192170 (7.3%) | −237.6 | −235.1 | 0.26 |
| TCF12 SRX190356 | SK-N-SH Neural | 999 / 19217 (5.2%) | 24078 / 192170 (12.5%) | −237.6 | −235.0 | 0.41 |
| ESR1 SRX20282955 | MCF-7 Breast | 348 / 19217 (1.8%) | 13761 / 192170 (7.2%) | −235.8 | −233.3 | 0.25 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 616 / 19217 (3.2%) | 18210 / 192170 (9.5%) | −234.8 | −232.2 | 0.34 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1189 / 19217 (6.2%) | 26660 / 192170 (13.9%) | −234.6 | −232.1 | 0.45 |
| FOXA1 SRX371481 | MCF-7 Breast | 373 / 19217 (1.9%) | 14159 / 192170 (7.4%) | −234.4 | −231.8 | 0.26 |
| FOXA1 SRX371482 | MCF-7 Breast | 527 / 19217 (2.7%) | 16763 / 192170 (8.7%) | −234.3 | −231.8 | 0.31 |
| JUNB SRX8488073 | SUM 229PE Breast | 677 / 19217 (3.5%) | 19148 / 192170 (10.0%) | −234.2 | −231.7 | 0.35 |
| FOXA1 SRX1161177 | MCF-7 Breast | 360 / 19217 (1.9%) | 13838 / 192170 (7.2%) | −231.4 | −228.9 | 0.26 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 514 / 19217 (2.7%) | 16435 / 192170 (8.6%) | −230.8 | −228.2 | 0.31 |
| YAP1 SRX5718140 | 293 Kidney | 612 / 19217 (3.2%) | 18006 / 192170 (9.4%) | −230.6 | −228.0 | 0.34 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1111 / 19217 (5.8%) | 25378 / 192170 (13.2%) | −229.7 | −227.2 | 0.44 |
| ESR1 SRX10365536 | MCF-7 Breast | 151 / 19217 (0.8%) | 9727 / 192170 (5.1%) | −228.9 | −226.4 | 0.16 |
| ESR1 SRX371476 | MCF-7 Breast | 245 / 19217 (1.3%) | 11629 / 192170 (6.1%) | −228.5 | −226.0 | 0.21 |
| ESR1 SRX2881002 | MCF-7 Breast | 316 / 19217 (1.6%) | 12951 / 192170 (6.7%) | −228.2 | −225.7 | 0.24 |
| FOS SRX150476 | MCF 10A Breast | 649 / 19217 (3.4%) | 18504 / 192170 (9.6%) | −228.1 | −225.6 | 0.35 |
| Epitope tags SRX5877913 | U2OS Bone | 2147 / 19217 (11.2%) | 38971 / 192170 (20.3%) | −227.9 | −225.4 | 0.55 |
| TP53 SRX19538269 | U2OS Bone | 478 / 19217 (2.5%) | 501 / 192170 (0.3%) | −227.4 | −224.9 | 9.54 |
| SMARCA4 SRX5212357 | Mel270 Others | 515 / 19217 (2.7%) | 16326 / 192170 (8.5%) | −226.9 | −224.4 | 0.32 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 652 / 19217 (3.4%) | 1103 / 192170 (0.6%) | −226.5 | −224.0 | 5.91 |
| SMARCA4 SRX5212371 | Mel270 Others | 502 / 19217 (2.6%) | 16088 / 192170 (8.4%) | −226.1 | −223.6 | 0.31 |
| SMARCA4 SRX5212366 | Mel270 Others | 473 / 19217 (2.5%) | 15594 / 192170 (8.1%) | −225.6 | −223.1 | 0.30 |
| ESR1 SRX20282971 | MCF-7 Breast | 335 / 19217 (1.7%) | 13204 / 192170 (6.9%) | −225.2 | −222.8 | 0.25 |
| ESR1 SRX2881000 | MCF-7 Breast | 290 / 19217 (1.5%) | 12376 / 192170 (6.4%) | −225.0 | −222.5 | 0.23 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 536 / 19217 (2.8%) | 16578 / 192170 (8.6%) | −224.2 | −221.7 | 0.32 |
| TLE3 SRX4815191 | MCF-7 Breast | 350 / 19217 (1.8%) | 13424 / 192170 (7.0%) | −223.8 | −221.4 | 0.26 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 642 / 19217 (3.3%) | 18231 / 192170 (9.5%) | −223.4 | −220.9 | 0.35 |
| Epitope tags SRX10549776 | K-562 Blood | 1560 / 19217 (8.1%) | 5852 / 192170 (3.0%) | −222.4 | −219.9 | 2.67 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1098 / 19217 (5.7%) | 24875 / 192170 (12.9%) | −221.4 | −219.0 | 0.44 |
| ESR1 SRX371468 | MCF-7 Breast | 213 / 19217 (1.1%) | 10791 / 192170 (5.6%) | −221.2 | −218.7 | 0.20 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1003 / 19217 (5.2%) | 23510 / 192170 (12.2%) | −220.9 | −218.5 | 0.43 |
| AR SRX10820653 | LNCAP Prostate | 362 / 19217 (1.9%) | 221 / 192170 (0.1%) | −220.7 | −218.3 | 16.38 |
| FOXA1 SRX3931044 | MCF-7 Breast | 826 / 19217 (4.3%) | 20929 / 192170 (10.9%) | −220.7 | −218.3 | 0.39 |
| JUN SRX6582171 | GM07492 Others | 733 / 19217 (3.8%) | 19511 / 192170 (10.2%) | −219.9 | −217.4 | 0.38 |
| ESR1 SRX20282953 | MCF-7 Breast | 273 / 19217 (1.4%) | 11889 / 192170 (6.2%) | −219.2 | −216.8 | 0.23 |
| ESR1 SRX371471 | ZR-75-1 Breast | 407 / 19217 (2.1%) | 14272 / 192170 (7.4%) | −219.2 | −216.7 | 0.29 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 650 / 19217 (3.4%) | 18207 / 192170 (9.5%) | −219.0 | −216.6 | 0.36 |
| ESR1 SRX194572 | MCF-7 Breast | 214 / 19217 (1.1%) | 10735 / 192170 (5.6%) | −218.5 | −216.1 | 0.20 |
| FOXA1 SRX371483 | MCF-7 Breast | 432 / 19217 (2.2%) | 14659 / 192170 (7.6%) | −217.9 | −215.5 | 0.29 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 963 / 19217 (5.0%) | 22809 / 192170 (11.9%) | −217.5 | −215.1 | 0.42 |
| FOXA1 SRX1161176 | MCF-7 Breast | 355 / 19217 (1.8%) | 13312 / 192170 (6.9%) | −217.3 | −214.9 | 0.27 |
| NR3C1 SRX2609664 | HASM2 Lung | 516 / 19217 (2.7%) | 15980 / 192170 (8.3%) | −215.9 | −213.5 | 0.32 |
| RAC1 SRX10365543 | MCF-7 Breast | 166 / 19217 (0.9%) | 9679 / 192170 (5.0%) | −215.7 | −213.3 | 0.17 |
| RAC1 SRX10365541 | MCF-7 Breast | 168 / 19217 (0.9%) | 9715 / 192170 (5.1%) | −215.4 | −213.0 | 0.17 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 476 / 19217 (2.5%) | 15302 / 192170 (8.0%) | −215.2 | −212.8 | 0.31 |
| FOS SRX4192879 | MCF 10A Breast | 432 / 19217 (2.2%) | 14544 / 192170 (7.6%) | −214.5 | −212.1 | 0.30 |
| VGLL1 SRX24602130 | BT-20 Breast | 372 / 19217 (1.9%) | 13499 / 192170 (7.0%) | −213.7 | −211.3 | 0.28 |
| NR2F2 SRX190293 | MCF-7 Breast | 382 / 19217 (2.0%) | 13659 / 192170 (7.1%) | −213.3 | −210.9 | 0.28 |
| MAU2 SRX15710550 | Fibroblasts Others | 627 / 19217 (3.3%) | 17620 / 192170 (9.2%) | −212.4 | −210.0 | 0.36 |
| FOXA1 SRX1161173 | MCF-7 Breast | 295 / 19217 (1.5%) | 12073 / 192170 (6.3%) | −212.0 | −209.6 | 0.24 |
| ESR1 SRX371470 | ZR-75-1 Breast | 346 / 19217 (1.8%) | 12928 / 192170 (6.7%) | −210.0 | −207.6 | 0.27 |
| ESR1 SRX330067 | MCF-7 Breast | 326 / 19217 (1.7%) | 12560 / 192170 (6.5%) | −209.5 | −207.2 | 0.26 |
| TP53 SRX19538270 | U2OS Bone | 450 / 19217 (2.3%) | 490 / 192170 (0.3%) | −209.5 | −207.1 | 9.18 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 374 / 19217 (1.9%) | 13374 / 192170 (7.0%) | −208.8 | −206.4 | 0.28 |
| EP300 SRX2194266 | SUM 159PT Breast | 664 / 19217 (3.5%) | 18056 / 192170 (9.4%) | −208.5 | −206.1 | 0.37 |
| ESR1 SRX20282938 | MCF-7 Breast | 282 / 19217 (1.5%) | 11715 / 192170 (6.1%) | −208.0 | −205.7 | 0.24 |
| JUNB SRX8488074 | SUM 229PE Breast | 504 / 19217 (2.6%) | 15520 / 192170 (8.1%) | −208.0 | −205.6 | 0.32 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 498 / 19217 (2.6%) | 15376 / 192170 (8.0%) | −206.7 | −204.3 | 0.32 |
| FOXA1 SRX371480 | MCF-7 Breast | 246 / 19217 (1.3%) | 10981 / 192170 (5.7%) | −205.8 | −203.4 | 0.22 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 509 / 19217 (2.6%) | 15495 / 192170 (8.1%) | −204.9 | −202.5 | 0.33 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1521 / 19217 (7.9%) | 5895 / 192170 (3.1%) | −204.8 | −202.5 | 2.58 |
| NR3C1 SRX2609659 | HASM2 Lung | 441 / 19217 (2.3%) | 14354 / 192170 (7.5%) | −204.1 | −201.7 | 0.31 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 521 / 19217 (2.7%) | 752 / 192170 (0.4%) | −203.3 | −200.9 | 6.93 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 288 / 19217 (1.5%) | 11680 / 192170 (6.1%) | −203.2 | −200.9 | 0.25 |
| FOXA1 SRX100454 | T-47D Breast | 512 / 19217 (2.7%) | 15451 / 192170 (8.0%) | −202.2 | −199.8 | 0.33 |
| FOXA1 SRX1161175 | MCF-7 Breast | 290 / 19217 (1.5%) | 11679 / 192170 (6.1%) | −202.1 | −199.7 | 0.25 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 773 / 19217 (4.0%) | 19457 / 192170 (10.1%) | −201.9 | −199.6 | 0.40 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 285 / 19217 (1.5%) | 11566 / 192170 (6.0%) | −201.3 | −199.0 | 0.25 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 671 / 19217 (3.5%) | 17899 / 192170 (9.3%) | −201.2 | −198.9 | 0.37 |
| ESR1 SRX3110725 | MCF-7 Breast | 335 / 19217 (1.7%) | 12444 / 192170 (6.5%) | −200.8 | −198.5 | 0.27 |
| GATA3 SRX176864 | MCF-7 Breast | 283 / 19217 (1.5%) | 11510 / 192170 (6.0%) | −200.5 | −198.2 | 0.25 |
| ESR1 SRX371477 | MCF-7 Breast | 173 / 19217 (0.9%) | 9397 / 192170 (4.9%) | −200.5 | −198.2 | 0.18 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 712 / 19217 (3.7%) | 1536 / 192170 (0.8%) | −200.4 | −198.1 | 4.64 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 584 / 19217 (3.0%) | 16532 / 192170 (8.6%) | −200.3 | −198.0 | 0.35 |
| ARID1A SRX5089376 | MCF-7 Breast | 330 / 19217 (1.7%) | 12333 / 192170 (6.4%) | −200.0 | −197.7 | 0.27 |
| ARID5B SRX3230377 | Hep G2 Liver | 1003 / 19217 (5.2%) | 22697 / 192170 (11.8%) | −199.8 | −197.5 | 0.44 |
| ESR1 SRX10365558 | MCF-7 Breast | 239 / 19217 (1.2%) | 10670 / 192170 (5.6%) | −199.8 | −197.5 | 0.22 |
| FOXA1 SRX1161174 | MCF-7 Breast | 402 / 19217 (2.1%) | 13563 / 192170 (7.1%) | −199.7 | −197.4 | 0.30 |
| GATA3 SRX5057632 | MCF-7 Breast | 242 / 19217 (1.3%) | 10717 / 192170 (5.6%) | −199.5 | −197.2 | 0.23 |
| NR3C1 SRX2609665 | HASM2 Lung | 423 / 19217 (2.2%) | 13908 / 192170 (7.2%) | −199.4 | −197.2 | 0.30 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1433 / 19217 (7.5%) | 28548 / 192170 (14.9%) | −199.4 | −197.1 | 0.50 |
| ESR1 SRX8537722 | MCF-7 Breast | 349 / 19217 (1.8%) | 12640 / 192170 (6.6%) | −199.3 | −197.0 | 0.28 |
| ESR1 SRX11120903 | MCF-7 Breast | 320 / 19217 (1.7%) | 12099 / 192170 (6.3%) | −198.3 | −196.0 | 0.26 |
| JUNB SRX10119386 | MCF 10A Breast | 349 / 19217 (1.8%) | 12597 / 192170 (6.6%) | −197.9 | −195.7 | 0.28 |
| JUN SRX6582172 | Fibroblasts Others | 523 / 19217 (2.7%) | 15475 / 192170 (8.1%) | −197.7 | −195.4 | 0.34 |
| ESR1 SRX20282946 | MCF-7 Breast | 215 / 19217 (1.1%) | 10148 / 192170 (5.3%) | −197.7 | −195.4 | 0.21 |
| Epitope tags SRX5877911 | U2OS Bone | 2064 / 19217 (10.7%) | 36562 / 192170 (19.0%) | −197.6 | −195.3 | 0.56 |
| JUN SRX4192884 | MCF 10A Breast | 323 / 19217 (1.7%) | 12103 / 192170 (6.3%) | −196.6 | −194.4 | 0.27 |
| AR SRX10820651 | LNCAP Prostate | 376 / 19217 (2.0%) | 328 / 192170 (0.2%) | −196.6 | −194.4 | 11.46 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 791 / 19217 (4.1%) | 19528 / 192170 (10.2%) | −196.6 | −194.3 | 0.41 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 535 / 19217 (2.8%) | 15627 / 192170 (8.1%) | −196.5 | −194.3 | 0.34 |
| ESR1 SRX330069 | MCF-7 Breast | 221 / 19217 (1.2%) | 10227 / 192170 (5.3%) | −196.5 | −194.2 | 0.22 |
| NR3C1 SRX2609661 | HASM2 Lung | 432 / 19217 (2.2%) | 13946 / 192170 (7.3%) | −196.1 | −193.9 | 0.31 |
| JUN SRX883584 | MDA-MB-231 Breast | 629 / 19217 (3.3%) | 17070 / 192170 (8.9%) | −195.9 | −193.6 | 0.37 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 387 / 19217 (2.0%) | 13176 / 192170 (6.9%) | −195.6 | −193.3 | 0.29 |
| TP53 SRX19538282 | Osteoblasts Bone | 388 / 19217 (2.0%) | 366 / 192170 (0.2%) | −195.1 | −192.9 | 10.60 |
| NR3C1 SRX2609662 | HASM2 Lung | 469 / 19217 (2.4%) | 14518 / 192170 (7.6%) | −195.1 | −192.8 | 0.32 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 356 / 19217 (1.9%) | 12627 / 192170 (6.6%) | −195.0 | −192.8 | 0.28 |
| ESR1 SRX5323871 | MCF-7 Breast | 424 / 19217 (2.2%) | 13774 / 192170 (7.2%) | −194.9 | −192.6 | 0.31 |
| KAT7 SRX101303 | RKO Digestive tract | 1482 / 19217 (7.7%) | 5830 / 192170 (3.0%) | −194.2 | −192.0 | 2.54 |
| STAT3 SRX2020842 | HCC70 Breast | 718 / 19217 (3.7%) | 18339 / 192170 (9.5%) | −193.7 | −191.5 | 0.39 |
| ESR1 SRX371475 | BT-474 Breast | 181 / 19217 (0.9%) | 9357 / 192170 (4.9%) | −193.5 | −191.3 | 0.19 |
| ESR1 SRX5323873 | MCF-7 Breast | 491 / 19217 (2.6%) | 14796 / 192170 (7.7%) | −192.8 | −190.5 | 0.33 |
| ESR1 SRX2943591 | MCF-7 Breast | 271 / 19217 (1.4%) | 11048 / 192170 (5.7%) | −192.6 | −190.4 | 0.25 |
| JUNB SRX8488089 | SUM 229PE Breast | 400 / 19217 (2.1%) | 13297 / 192170 (6.9%) | −192.6 | −190.4 | 0.30 |
| ESR1 SRX2513517 | MCF-7 Breast | 248 / 19217 (1.3%) | 10608 / 192170 (5.5%) | −192.2 | −190.0 | 0.23 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1174 / 19217 (6.1%) | 24754 / 192170 (12.9%) | −191.9 | −189.7 | 0.47 |
| JUNB SRX4192882 | MCF 10A Breast | 310 / 19217 (1.6%) | 11718 / 192170 (6.1%) | −191.7 | −189.5 | 0.26 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 173 / 19217 (0.9%) | 9117 / 192170 (4.7%) | −190.7 | −188.5 | 0.19 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 435 / 19217 (2.3%) | 13791 / 192170 (7.2%) | −190.0 | −187.8 | 0.32 |
| BMI1 SRX644729 | 293 Kidney | 284 / 19217 (1.5%) | 133 / 192170 (0.1%) | −190.0 | −187.8 | 21.35 |
| ESR1 SRX10365532 | MCF-7 Breast | 200 / 19217 (1.0%) | 9618 / 192170 (5.0%) | −189.6 | −187.4 | 0.21 |
| ESR1 SRX330070 | MCF-7 Breast | 190 / 19217 (1.0%) | 9410 / 192170 (4.9%) | −189.2 | −187.0 | 0.20 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 711 / 19217 (3.7%) | 1624 / 192170 (0.8%) | −189.2 | −186.9 | 4.38 |
| FOSL2 SRX190296 | SK-N-SH Neural | 542 / 19217 (2.8%) | 15467 / 192170 (8.0%) | −188.7 | −186.5 | 0.35 |
| PBX3 SRX190343 | SK-N-SH Neural | 866 / 19217 (4.5%) | 20315 / 192170 (10.6%) | −188.7 | −186.5 | 0.43 |
| YAP1 SRX10119364 | MCF 10A Breast | 331 / 19217 (1.7%) | 11970 / 192170 (6.2%) | −187.9 | −185.7 | 0.28 |
| BRD1 SRX286203 | RKO Digestive tract | 1279 / 19217 (6.7%) | 4694 / 192170 (2.4%) | −187.6 | −185.4 | 2.72 |
| EP300 SRX2671813 | Fibroblasts Others | 328 / 19217 (1.7%) | 11901 / 192170 (6.2%) | −187.5 | −185.3 | 0.28 |
| ARID1A SRX5089379 | MCF-7 Breast | 398 / 19217 (2.1%) | 13094 / 192170 (6.8%) | −187.4 | −185.2 | 0.30 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 621 / 19217 (3.2%) | 16633 / 192170 (8.7%) | −187.0 | −184.8 | 0.37 |
| ESR1 SRX1012629 | MCF-7 Breast | 237 / 19217 (1.2%) | 10247 / 192170 (5.3%) | −187.0 | −184.8 | 0.23 |
| FOXA1 SRX1787653 | MCF-7 Breast | 330 / 19217 (1.7%) | 11921 / 192170 (6.2%) | −186.9 | −184.7 | 0.28 |
| ESR1 SRX1469949 | MCF-7 Breast | 213 / 19217 (1.1%) | 9787 / 192170 (5.1%) | −186.8 | −184.6 | 0.22 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 752 / 19217 (3.9%) | 18583 / 192170 (9.7%) | −186.6 | −184.4 | 0.40 |
| IRF3 SRX11453858 | Hep G2 Liver | 274 / 19217 (1.4%) | 122 / 192170 (0.1%) | −186.2 | −184.0 | 22.46 |
| ESR1 SRX8537723 | MCF-7 Breast | 317 / 19217 (1.6%) | 11647 / 192170 (6.1%) | −185.5 | −183.3 | 0.27 |
| TLE3 SRX4815192 | MCF-7 Breast | 371 / 19217 (1.9%) | 12575 / 192170 (6.5%) | −185.4 | −183.2 | 0.30 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 803 / 19217 (4.2%) | 19278 / 192170 (10.0%) | −185.4 | −183.2 | 0.42 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 382 / 19217 (2.0%) | 12732 / 192170 (6.6%) | −184.5 | −182.4 | 0.30 |
| ESR1 SRX10365533 | MCF-7 Breast | 176 / 19217 (0.9%) | 8990 / 192170 (4.7%) | −184.3 | −182.1 | 0.20 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 385 / 19217 (2.0%) | 12762 / 192170 (6.6%) | −183.9 | −181.7 | 0.30 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 375 / 19217 (2.0%) | 12593 / 192170 (6.6%) | −183.9 | −181.7 | 0.30 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 930 / 19217 (4.8%) | 21023 / 192170 (10.9%) | −183.4 | −181.2 | 0.44 |
| ESR1 SRX5323872 | MCF-7 Breast | 407 / 19217 (2.1%) | 13107 / 192170 (6.8%) | −183.2 | −181.0 | 0.31 |
| PRRX1 SRX15235713 | Hs 578T Breast | 505 / 19217 (2.6%) | 14686 / 192170 (7.6%) | −183.1 | −180.9 | 0.34 |
| NR3C1 SRX2609666 | HASM2 Lung | 390 / 19217 (2.0%) | 12813 / 192170 (6.7%) | −182.9 | −180.7 | 0.30 |
| WWTR1 SRX10119367 | MCF 10A Breast | 486 / 19217 (2.5%) | 14378 / 192170 (7.5%) | −182.9 | −180.7 | 0.34 |
| TEAD1 SRX3401272 | MCF-7 Breast | 302 / 19217 (1.6%) | 11296 / 192170 (5.9%) | −182.7 | −180.5 | 0.27 |
| ESR1 SRX20282959 | MCF-7 Breast | 147 / 19217 (0.8%) | 8333 / 192170 (4.3%) | −182.0 | −179.9 | 0.18 |
| ESR1 SRX1531796 | MCF-7 Breast | 203 / 19217 (1.1%) | 9455 / 192170 (4.9%) | −182.0 | −179.9 | 0.21 |
| PGR SRX1012655 | MCF-7 Breast | 252 / 19217 (1.3%) | 10371 / 192170 (5.4%) | −181.9 | −179.8 | 0.24 |
| ESR1 SRX2912055 | MCF-7 Breast | 137 / 19217 (0.7%) | 8117 / 192170 (4.2%) | −181.7 | −179.6 | 0.17 |
| ESR1 SRX371474 | BT-474 Breast | 176 / 19217 (0.9%) | 8907 / 192170 (4.6%) | −181.5 | −179.3 | 0.20 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 456 / 19217 (2.4%) | 13837 / 192170 (7.2%) | −181.2 | −179.0 | 0.33 |
| EP300 SRX2194265 | SUM 159PT Breast | 662 / 19217 (3.4%) | 17035 / 192170 (8.9%) | −181.0 | −178.8 | 0.39 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 417 / 19217 (2.2%) | 13172 / 192170 (6.9%) | −180.2 | −178.1 | 0.32 |
| CEBPB SRX150632 | HeLa Uterus | 964 / 19217 (5.0%) | 21346 / 192170 (11.1%) | −179.5 | −177.3 | 0.45 |
| ESR1 SRX1012632 | MCF-7 Breast | 191 / 19217 (1.0%) | 9136 / 192170 (4.8%) | −179.2 | −177.1 | 0.21 |
| JUND SRX190357 | SK-N-SH Neural | 526 / 19217 (2.7%) | 14881 / 192170 (7.7%) | −179.1 | −176.9 | 0.35 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 397 / 19217 (2.1%) | 12794 / 192170 (6.7%) | −178.8 | −176.6 | 0.31 |
| STAT3 SRX150479 | MCF 10A Breast | 394 / 19217 (2.1%) | 12741 / 192170 (6.6%) | −178.7 | −176.6 | 0.31 |
| ESR1 SRX3123829 | MCF-7 Breast | 228 / 19217 (1.2%) | 9827 / 192170 (5.1%) | −178.6 | −176.5 | 0.23 |
| ESR1 SRX2513520 | MCF-7 Breast | 246 / 19217 (1.3%) | 10154 / 192170 (5.3%) | −178.5 | −176.3 | 0.24 |
| JUNB SRX10119383 | MCF 10A Breast | 279 / 19217 (1.5%) | 10748 / 192170 (5.6%) | −178.3 | −176.2 | 0.26 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 602 / 19217 (3.1%) | 16017 / 192170 (8.3%) | −178.1 | −176.0 | 0.38 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 563 / 19217 (2.9%) | 15416 / 192170 (8.0%) | −178.0 | −175.9 | 0.37 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 743 / 19217 (3.9%) | 18125 / 192170 (9.4%) | −178.0 | −175.9 | 0.41 |
| FOXA1 SRX11222441 | MCF-7 Breast | 326 / 19217 (1.7%) | 11560 / 192170 (6.0%) | −177.8 | −175.7 | 0.28 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 425 / 19217 (2.2%) | 13210 / 192170 (6.9%) | −177.6 | −175.5 | 0.32 |
| FOXA1 SRX3923514 | MCF-7 Breast | 440 / 19217 (2.3%) | 13455 / 192170 (7.0%) | −177.5 | −175.4 | 0.33 |
| ESR1 SRX5323878 | MCF-7 Breast | 418 / 19217 (2.2%) | 13091 / 192170 (6.8%) | −177.4 | −175.3 | 0.32 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 343 / 19217 (1.8%) | 11833 / 192170 (6.2%) | −177.3 | −175.2 | 0.29 |
| JUN SRX6582163 | BJ-5ta Epidermis | 530 / 19217 (2.8%) | 14873 / 192170 (7.7%) | −177.1 | −175.0 | 0.36 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 393 / 19217 (2.0%) | 12669 / 192170 (6.6%) | −177.1 | −174.9 | 0.31 |
| FOXL2 SRX6957431 | KGN Gonad | 982 / 19217 (5.1%) | 21494 / 192170 (11.2%) | −176.9 | −174.8 | 0.46 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 715 / 19217 (3.7%) | 17668 / 192170 (9.2%) | −176.8 | −174.7 | 0.40 |
| ESR1 SRX2513521 | MCF-7 Breast | 183 / 19217 (1.0%) | 8900 / 192170 (4.6%) | −176.5 | −174.4 | 0.21 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 977 / 19217 (5.1%) | 21391 / 192170 (11.1%) | −176.1 | −174.0 | 0.46 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 364 / 19217 (1.9%) | 12153 / 192170 (6.3%) | −176.1 | −174.0 | 0.30 |
| ESR1 SRX4451213 | MCF-7 Breast | 432 / 19217 (2.2%) | 13270 / 192170 (6.9%) | −176.0 | −173.9 | 0.33 |
| STAT3 SRX150630 | MCF 10A Breast | 397 / 19217 (2.1%) | 12688 / 192170 (6.6%) | −175.7 | −173.6 | 0.31 |
| ESR1 SRX5323877 | MCF-7 Breast | 322 / 19217 (1.7%) | 11412 / 192170 (5.9%) | −175.4 | −173.3 | 0.28 |
| BRPF3 SRX796084 | RKO Digestive tract | 1603 / 19217 (8.3%) | 6955 / 192170 (3.6%) | −175.2 | −173.1 | 2.30 |
| SOX13 SRX2636248 | Hep G2 Liver | 585 / 19217 (3.0%) | 15654 / 192170 (8.1%) | −175.1 | −173.0 | 0.37 |
| FOXA1 SRX028634 | MCF-7 Breast | 199 / 19217 (1.0%) | 9168 / 192170 (4.8%) | −175.1 | −173.0 | 0.22 |
| YAP1 SRX1038945 | IMR-90 Lung | 310 / 19217 (1.6%) | 11188 / 192170 (5.8%) | −174.9 | −172.8 | 0.28 |
| EP300 SRX1012648 | MCF-7 Breast | 188 / 19217 (1.0%) | 8950 / 192170 (4.7%) | −174.7 | −172.6 | 0.21 |
| JUN SRX7277180 | GM07492 Others | 348 / 19217 (1.8%) | 11834 / 192170 (6.2%) | −174.7 | −172.6 | 0.29 |
| ESR1 SRX2881001 | MCF-7 Breast | 217 / 19217 (1.1%) | 9495 / 192170 (4.9%) | −174.5 | −172.4 | 0.23 |
| ESR1 SRX1469951 | MCF-7 Breast | 207 / 19217 (1.1%) | 9304 / 192170 (4.8%) | −174.5 | −172.4 | 0.22 |
| FOXA1 SRX11222437 | MCF-7 Breast | 310 / 19217 (1.6%) | 11164 / 192170 (5.8%) | −174.1 | −172.1 | 0.28 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 341 / 19217 (1.8%) | 11697 / 192170 (6.1%) | −174.1 | −172.0 | 0.29 |
| AR SRX9109110 | MDA-MB-453 Breast | 821 / 19217 (4.3%) | 19097 / 192170 (9.9%) | −173.9 | −171.9 | 0.43 |
| ARID1A SRX5089385 | MCF-7 Breast | 310 / 19217 (1.6%) | 11145 / 192170 (5.8%) | −173.6 | −171.5 | 0.28 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 549 / 19217 (2.9%) | 15041 / 192170 (7.8%) | −173.6 | −171.5 | 0.37 |
| ZEB1 SRX13298925 | MCF-7 Breast | 253 / 19217 (1.3%) | 10133 / 192170 (5.3%) | −173.5 | −171.4 | 0.25 |
| FOXA2 SRX3230382 | Hep G2 Liver | 588 / 19217 (3.1%) | 15637 / 192170 (8.1%) | −173.5 | −171.4 | 0.38 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 413 / 19217 (2.1%) | 12870 / 192170 (6.7%) | −173.3 | −171.3 | 0.32 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 198 / 19217 (1.0%) | 9100 / 192170 (4.7%) | −173.3 | −171.2 | 0.22 |
| EP300 SRX176885 | MCF-7 Breast | 210 / 19217 (1.1%) | 9327 / 192170 (4.9%) | −173.3 | −171.2 | 0.23 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 389 / 19217 (2.0%) | 12455 / 192170 (6.5%) | −172.7 | −170.6 | 0.31 |
| BRPF3 SRX796085 | RKO Digestive tract | 1142 / 19217 (5.9%) | 4108 / 192170 (2.1%) | −172.4 | −170.3 | 2.78 |
| BRD4 SRX736204 | 90-8TL Neural | 998 / 19217 (5.2%) | 3280 / 192170 (1.7%) | −172.2 | −170.2 | 3.04 |
| AHR SRX20282969 | MCF-7 Breast | 181 / 19217 (0.9%) | 8732 / 192170 (4.5%) | −172.1 | −170.0 | 0.21 |
| FOS SRX3322636 | MCF-7 Breast | 278 / 19217 (1.4%) | 10516 / 192170 (5.5%) | −171.5 | −169.4 | 0.26 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 495 / 19217 (2.6%) | 839 / 192170 (0.4%) | −171.4 | −169.4 | 5.90 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 308 / 19217 (1.6%) | 11039 / 192170 (5.7%) | −171.3 | −169.3 | 0.28 |
| RNF2 SRX18954719 | SCC-25 Others | 588 / 19217 (3.1%) | 15545 / 192170 (8.1%) | −171.0 | −168.9 | 0.38 |
| ESR1 SRX1012633 | MCF-7 Breast | 211 / 19217 (1.1%) | 9265 / 192170 (4.8%) | −170.6 | −168.6 | 0.23 |
| FOXA2 SRX100448 | Hep G2 Liver | 481 / 19217 (2.5%) | 13863 / 192170 (7.2%) | −170.4 | −168.3 | 0.35 |
| JUNB SRX10119384 | MCF 10A Breast | 257 / 19217 (1.3%) | 10103 / 192170 (5.3%) | −170.3 | −168.3 | 0.25 |
| GATAD2A SRX2636506 | Hep G2 Liver | 555 / 19217 (2.9%) | 15017 / 192170 (7.8%) | −170.3 | −168.2 | 0.37 |
| FOXA1 SRX028635 | MCF-7 Breast | 208 / 19217 (1.1%) | 9182 / 192170 (4.8%) | −169.7 | −167.6 | 0.23 |
| FOXA1 SRX11222442 | MCF-7 Breast | 294 / 19217 (1.5%) | 10738 / 192170 (5.6%) | −169.5 | −167.4 | 0.27 |
| ARID5B SRX10475138 | Hep G2 Liver | 728 / 19217 (3.8%) | 17556 / 192170 (9.1%) | −168.9 | −166.9 | 0.41 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 417 / 19217 (2.2%) | 12779 / 192170 (6.6%) | −168.7 | −166.7 | 0.33 |
| ESR1 SRX2513519 | MCF-7 Breast | 223 / 19217 (1.2%) | 9417 / 192170 (4.9%) | −168.2 | −166.1 | 0.24 |
| JUN SRX6582165 | BJ-5ta Epidermis | 840 / 19217 (4.4%) | 19139 / 192170 (10.0%) | −168.0 | −166.0 | 0.44 |
| AGO2 SRX6783957 | Hep G2 Liver | 1299 / 19217 (6.8%) | 5135 / 192170 (2.7%) | −167.9 | −165.9 | 2.53 |
| SMC1A SRX1013334 | HuCCT1 Liver | 1247 / 19217 (6.5%) | 24704 / 192170 (12.9%) | −167.4 | −165.4 | 0.50 |
| SSRP1 SRX3436567 | HT-1080 Bone | 433 / 19217 (2.3%) | 633 / 192170 (0.3%) | −167.4 | −165.3 | 6.84 |
| JUN SRX6582164 | BJ-5ta Epidermis | 560 / 19217 (2.9%) | 14975 / 192170 (7.8%) | −167.0 | −165.0 | 0.37 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 264 / 19217 (1.4%) | 146 / 192170 (0.1%) | −167.0 | −165.0 | 18.08 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 572 / 19217 (3.0%) | 15160 / 192170 (7.9%) | −167.0 | −165.0 | 0.38 |
| EP300 SRX100540 | SK-N-SH Neural | 642 / 19217 (3.3%) | 16187 / 192170 (8.4%) | −166.2 | −164.2 | 0.40 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 467 / 19217 (2.4%) | 13488 / 192170 (7.0%) | −166.0 | −163.9 | 0.35 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 812 / 19217 (4.2%) | 18655 / 192170 (9.7%) | −165.9 | −163.9 | 0.44 |
| AR SRX9109113 | MDA-MB-453 Breast | 854 / 19217 (4.4%) | 19246 / 192170 (10.0%) | −165.8 | −163.8 | 0.44 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 778 / 19217 (4.0%) | 18161 / 192170 (9.5%) | −165.8 | −163.7 | 0.43 |
| ESR1 SRX2943589 | MCF-7 Breast | 221 / 19217 (1.2%) | 9303 / 192170 (4.8%) | −165.6 | −163.6 | 0.24 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 622 / 19217 (3.2%) | 15865 / 192170 (8.3%) | −165.6 | −163.6 | 0.39 |
| MITF SRX7368256 | Hermes 3C Epidermis | 860 / 19217 (4.5%) | 19319 / 192170 (10.1%) | −165.5 | −163.5 | 0.45 |
| ESR1 SRX3110723 | MCF-7 Breast | 231 / 19217 (1.2%) | 9475 / 192170 (4.9%) | −165.3 | −163.3 | 0.24 |
| AGO2 SRX6783958 | Hep G2 Liver | 1274 / 19217 (6.6%) | 5033 / 192170 (2.6%) | −164.8 | −162.8 | 2.53 |
| ASPSCR1 SRX17321275 | ASPS1 Lung | 753 / 19217 (3.9%) | 17762 / 192170 (9.2%) | −164.8 | −162.8 | 0.42 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 965 / 19217 (5.0%) | 3194 / 192170 (1.7%) | −164.8 | −162.7 | 3.02 |
| FOXA1 SRX1447317 | MCF-7 Breast | 288 / 19217 (1.5%) | 10470 / 192170 (5.4%) | −164.4 | −162.4 | 0.28 |
| ESR1 SRX1995229 | MCF-7 Breast | 441 / 19217 (2.3%) | 12997 / 192170 (6.8%) | −163.7 | −161.6 | 0.34 |
| ESR1 SRX2513518 | MCF-7 Breast | 202 / 19217 (1.1%) | 8884 / 192170 (4.6%) | −163.5 | −161.5 | 0.23 |
| RELA SRX5938177 | FaDu Others | 408 / 19217 (2.1%) | 12452 / 192170 (6.5%) | −163.3 | −161.3 | 0.33 |
| TP53 SRX19538271 | U2OS Bone | 623 / 19217 (3.2%) | 1443 / 192170 (0.8%) | −163.2 | −161.2 | 4.32 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 704 / 19217 (3.7%) | 16985 / 192170 (8.8%) | −163.2 | −161.2 | 0.41 |
| GATA3 SRX5457550 | MCF-7 Breast | 510 / 19217 (2.7%) | 14059 / 192170 (7.3%) | −163.0 | −161.0 | 0.36 |
| ZEB1 SRX13298924 | MCF-7 Breast | 201 / 19217 (1.0%) | 8848 / 192170 (4.6%) | −163.0 | −161.0 | 0.23 |
| ESR1 SRX330068 | MCF-7 Breast | 201 / 19217 (1.0%) | 8844 / 192170 (4.6%) | −162.9 | −160.9 | 0.23 |
| EP300 SRX176883 | MCF-7 Breast | 198 / 19217 (1.0%) | 8785 / 192170 (4.6%) | −162.8 | −160.8 | 0.23 |
| EP300 SRX1012644 | MCF-7 Breast | 193 / 19217 (1.0%) | 8688 / 192170 (4.5%) | −162.8 | −160.8 | 0.22 |
| SMARCA4 SRX8566546 | 786-O Kidney | 1531 / 19217 (8.0%) | 28204 / 192170 (14.7%) | −162.8 | −160.8 | 0.54 |
| FOXA1 SRX100506 | Hep G2 Liver | 595 / 19217 (3.1%) | 15353 / 192170 (8.0%) | −162.8 | −160.7 | 0.39 |
| FOXA1 SRX5323843 | MCF-7 Breast | 228 / 19217 (1.2%) | 9343 / 192170 (4.9%) | −162.7 | −160.7 | 0.24 |
| BRPF3 SRX796086 | RKO Digestive tract | 1520 / 19217 (7.9%) | 6658 / 192170 (3.5%) | −162.6 | −160.6 | 2.28 |
| ESR1 SRX5534831 | MCF-7 Breast | 340 / 19217 (1.8%) | 11298 / 192170 (5.9%) | −162.5 | −160.5 | 0.30 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 327 / 19217 (1.7%) | 11080 / 192170 (5.8%) | −162.5 | −160.5 | 0.30 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 379 / 19217 (2.0%) | 11946 / 192170 (6.2%) | −162.4 | −160.4 | 0.32 |
| SMARCA4 SRX15419260 | 786-O Kidney | 1533 / 19217 (8.0%) | 28186 / 192170 (14.7%) | −161.9 | −159.9 | 0.54 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 396 / 19217 (2.1%) | 12204 / 192170 (6.4%) | −161.9 | −159.9 | 0.32 |
| ESR1 SRX5323874 | MCF-7 Breast | 256 / 19217 (1.3%) | 9822 / 192170 (5.1%) | −161.8 | −159.8 | 0.26 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 531 / 19217 (2.8%) | 14340 / 192170 (7.5%) | −161.8 | −159.8 | 0.37 |
| ESR1 SRX1995230 | MCF-7 Breast | 374 / 19217 (1.9%) | 11842 / 192170 (6.2%) | −161.8 | −159.8 | 0.32 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1083 / 19217 (5.6%) | 22253 / 192170 (11.6%) | −161.8 | −159.8 | 0.49 |
| STAT3 SRX150536 | MCF 10A Breast | 509 / 19217 (2.6%) | 13996 / 192170 (7.3%) | −161.7 | −159.7 | 0.36 |
| NR3C1 SRX17639412 | A549 Lung | 502 / 19217 (2.6%) | 13881 / 192170 (7.2%) | −161.5 | −159.6 | 0.36 |
| ARID5B SRX10475139 | Hep G2 Liver | 483 / 19217 (2.5%) | 13585 / 192170 (7.1%) | −161.5 | −159.5 | 0.36 |
| EP300 SRX1012643 | MCF-7 Breast | 151 / 19217 (0.8%) | 7816 / 192170 (4.1%) | −161.1 | −159.1 | 0.19 |
| CDK9 SRX7366783 | MCF-7 Breast | 263 / 19217 (1.4%) | 159 / 192170 (0.1%) | −161.1 | −159.1 | 16.54 |
| FOXA1 SRX1787655 | MCF-7 Breast | 222 / 19217 (1.2%) | 9177 / 192170 (4.8%) | −160.9 | −158.9 | 0.24 |
| NR3C1 SRX19024866 | MCF-7 Breast | 148 / 19217 (0.8%) | 7750 / 192170 (4.0%) | −160.8 | −158.9 | 0.19 |
| ESR1 SRX1012628 | MCF-7 Breast | 222 / 19217 (1.2%) | 9171 / 192170 (4.8%) | −160.8 | −158.8 | 0.24 |
| TFAP2C SRX128099 | MCF-7 Breast | 404 / 19217 (2.1%) | 12299 / 192170 (6.4%) | −160.8 | −158.8 | 0.33 |
| ESR1 SRX1012625 | MCF-7 Breast | 230 / 19217 (1.2%) | 9312 / 192170 (4.8%) | −160.5 | −158.5 | 0.25 |
| ESR1 SRX1012630 | MCF-7 Breast | 164 / 19217 (0.9%) | 8055 / 192170 (4.2%) | −160.4 | −158.4 | 0.20 |
| TFAP2C SRX018833 | MCF-7 Breast | 405 / 19217 (2.1%) | 12301 / 192170 (6.4%) | −160.3 | −158.4 | 0.33 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 614 / 19217 (3.2%) | 15541 / 192170 (8.1%) | −160.2 | −158.3 | 0.40 |
| ESR1 SRX5534832 | MCF-7 Breast | 406 / 19217 (2.1%) | 12300 / 192170 (6.4%) | −159.9 | −158.0 | 0.33 |
| FOXA1 SRX1787651 | MCF-7 Breast | 257 / 19217 (1.3%) | 9779 / 192170 (5.1%) | −159.9 | −157.9 | 0.26 |
| ESR1 SRX4451212 | MCF-7 Breast | 431 / 19217 (2.2%) | 12698 / 192170 (6.6%) | −159.7 | −157.7 | 0.34 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 412 / 19217 (2.1%) | 12382 / 192170 (6.4%) | −159.5 | −157.5 | 0.33 |
| AR SRX9469988 | LAPC-4 Prostate | 611 / 19217 (3.2%) | 15463 / 192170 (8.0%) | −159.3 | −157.3 | 0.40 |
| RELA SRX7055007 | HAEC Cardiovascular | 817 / 19217 (4.3%) | 18436 / 192170 (9.6%) | −158.6 | −156.7 | 0.44 |
| TLE3 SRX4815194 | SUM 149PT Breast | 346 / 19217 (1.8%) | 11260 / 192170 (5.9%) | −158.3 | −156.3 | 0.31 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 358 / 19217 (1.9%) | 11459 / 192170 (6.0%) | −158.3 | −156.3 | 0.31 |
| ESR1 SRX20282966 | MCF-7 Breast | 149 / 19217 (0.8%) | 7691 / 192170 (4.0%) | −158.1 | −156.1 | 0.19 |
| CEBPA SRX2630241 | Hep G2 Liver | 557 / 19217 (2.9%) | 14600 / 192170 (7.6%) | −158.0 | −156.1 | 0.38 |
| AHR SRX2378695 | MCF-7 Breast | 183 / 19217 (1.0%) | 8353 / 192170 (4.3%) | −158.0 | −156.0 | 0.22 |
| CEBPB SRX2194250 | SUM 159PT Breast | 558 / 19217 (2.9%) | 14613 / 192170 (7.6%) | −157.9 | −155.9 | 0.38 |
| JUN SRX2355072 | HAEC Cardiovascular | 598 / 19217 (3.1%) | 15211 / 192170 (7.9%) | −157.8 | −155.8 | 0.39 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 435 / 19217 (2.3%) | 12693 / 192170 (6.6%) | −157.8 | −155.8 | 0.34 |
| NR3C1 SRX8520802 | HCC1187 Breast | 334 / 19217 (1.7%) | 11042 / 192170 (5.7%) | −157.8 | −155.8 | 0.30 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 583 / 19217 (3.0%) | 14978 / 192170 (7.8%) | −157.6 | −155.6 | 0.39 |
| FOXA1 SRX5203303 | MCF-7 Breast | 146 / 19217 (0.8%) | 7614 / 192170 (4.0%) | −157.5 | −155.5 | 0.19 |
| FOS SRX3322637 | MCF-7 Breast | 239 / 19217 (1.2%) | 9371 / 192170 (4.9%) | −157.3 | −155.3 | 0.26 |
| IRF3 SRX11453861 | Hep G2 Liver | 238 / 19217 (1.2%) | 116 / 192170 (0.1%) | −157.3 | −155.3 | 20.52 |
| ZEB1 SRX13298923 | MCF-7 Breast | 185 / 19217 (1.0%) | 8370 / 192170 (4.4%) | −157.2 | −155.2 | 0.22 |
| EP300 SRX150579 | HeLa Uterus | 305 / 19217 (1.6%) | 10522 / 192170 (5.5%) | −157.0 | −155.1 | 0.29 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 663 / 19217 (3.5%) | 16139 / 192170 (8.4%) | −156.7 | −154.8 | 0.41 |
| AR SRX1067067 | LHSAR Prostate | 783 / 19217 (4.1%) | 17875 / 192170 (9.3%) | −156.7 | −154.8 | 0.44 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 412 / 19217 (2.1%) | 12283 / 192170 (6.4%) | −156.6 | −154.7 | 0.34 |
| FOXA1 SRX3931054 | MCF-7 Breast | 435 / 19217 (2.3%) | 12649 / 192170 (6.6%) | −156.6 | −154.6 | 0.34 |
| FOXA1 SRX3931043 | MCF-7 Breast | 476 / 19217 (2.5%) | 13294 / 192170 (6.9%) | −156.5 | −154.5 | 0.36 |
| GATA3 SRX6712581 | MCF-7 Breast | 382 / 19217 (2.0%) | 11785 / 192170 (6.1%) | −156.3 | −154.4 | 0.32 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 346 / 19217 (1.8%) | 11188 / 192170 (5.8%) | −156.2 | −154.3 | 0.31 |
| NR3C1 SRX19024870 | MCF-7 Breast | 145 / 19217 (0.8%) | 7544 / 192170 (3.9%) | −155.9 | −154.0 | 0.19 |
| ARID1A SRX5089382 | MCF-7 Breast | 325 / 19217 (1.7%) | 10819 / 192170 (5.6%) | −155.6 | −153.7 | 0.30 |
| JUND SRX150408 | HeLa Uterus | 406 / 19217 (2.1%) | 12152 / 192170 (6.3%) | −155.6 | −153.6 | 0.33 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 312 / 19217 (1.6%) | 10593 / 192170 (5.5%) | −155.5 | −153.5 | 0.29 |
| FOXA1 SRX3923516 | MCF-7 Breast | 337 / 19217 (1.8%) | 11013 / 192170 (5.7%) | −155.4 | −153.5 | 0.31 |
| FOXA1 SRX11222438 | MCF-7 Breast | 248 / 19217 (1.3%) | 9472 / 192170 (4.9%) | −155.3 | −153.4 | 0.26 |
| RNF2 SRX18954702 | FaDu Others | 1029 / 19217 (5.4%) | 21241 / 192170 (11.1%) | −155.2 | −153.3 | 0.48 |
| CEBPB SRX190345 | MCF-7 Breast | 363 / 19217 (1.9%) | 11434 / 192170 (5.9%) | −155.1 | −153.2 | 0.32 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 293 / 19217 (1.5%) | 10254 / 192170 (5.3%) | −155.0 | −153.1 | 0.29 |
| FOXA1 SRX100477 | Hep G2 Liver | 523 / 19217 (2.7%) | 13965 / 192170 (7.3%) | −154.8 | −152.9 | 0.37 |
| NR3C1 SRX10976921 | A549 Lung | 325 / 19217 (1.7%) | 10789 / 192170 (5.6%) | −154.8 | −152.9 | 0.30 |
| ARID1A SRX5089391 | MCF-7 Breast | 256 / 19217 (1.3%) | 9569 / 192170 (5.0%) | −153.8 | −151.9 | 0.27 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 394 / 19217 (2.1%) | 11893 / 192170 (6.2%) | −153.7 | −151.7 | 0.33 |
| ESR1 SRX3110720 | MCF-7 Breast | 184 / 19217 (1.0%) | 8241 / 192170 (4.3%) | −153.7 | −151.7 | 0.22 |
| AR SRX1067066 | LHSAR Prostate | 976 / 19217 (5.1%) | 20447 / 192170 (10.6%) | −153.6 | −151.7 | 0.48 |
| ESR1 SRX176856 | MCF-7 Breast | 149 / 19217 (0.8%) | 7559 / 192170 (3.9%) | −153.6 | −151.7 | 0.20 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 511 / 19217 (2.7%) | 13734 / 192170 (7.1%) | −153.6 | −151.7 | 0.37 |
| WWTR1 SRX10119378 | MCF 10A Breast | 505 / 19217 (2.6%) | 13634 / 192170 (7.1%) | −153.4 | −151.5 | 0.37 |
| ESR1 SRX5287697 | MCF-7 Breast | 158 / 19217 (0.8%) | 7728 / 192170 (4.0%) | −153.3 | −151.4 | 0.20 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 833 / 19217 (4.3%) | 2612 / 192170 (1.4%) | −153.1 | −151.2 | 3.19 |
| FOXA1 SRX1787652 | MCF-7 Breast | 289 / 19217 (1.5%) | 10121 / 192170 (5.3%) | −153.0 | −151.1 | 0.29 |
| PROX1 SRX3230397 | Hep G2 Liver | 336 / 19217 (1.7%) | 10915 / 192170 (5.7%) | −152.9 | −151.0 | 0.31 |
| Epitope tags SRX15939724 | RD Muscle | 401 / 19217 (2.1%) | 11981 / 192170 (6.2%) | −152.9 | −151.0 | 0.33 |
| DAXX SRX1021630 | PC-3 Prostate | 474 / 19217 (2.5%) | 13136 / 192170 (6.8%) | −152.9 | −151.0 | 0.36 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 531 / 19217 (2.8%) | 1120 / 192170 (0.6%) | −152.4 | −150.5 | 4.74 |
| CBX3 SRX6712570 | MCF-7 Breast | 365 / 19217 (1.9%) | 11375 / 192170 (5.9%) | −152.3 | −150.4 | 0.32 |
| SMARCA4 SRX5075174 | Neural progenitor cells Neural | 747 / 19217 (3.9%) | 17183 / 192170 (8.9%) | −152.2 | −150.3 | 0.43 |
| FOXA2 SRX10475773 | Hep G2 Liver | 565 / 19217 (2.9%) | 14506 / 192170 (7.5%) | −152.2 | −150.3 | 0.39 |
| ESR1 SRX7427512 | MCF-7 Breast | 462 / 19217 (2.4%) | 12926 / 192170 (6.7%) | −152.2 | −150.3 | 0.36 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 437 / 19217 (2.3%) | 12529 / 192170 (6.5%) | −152.1 | −150.2 | 0.35 |
| ESR1 SRX1469950 | MCF-7 Breast | 162 / 19217 (0.8%) | 7765 / 192170 (4.0%) | −151.8 | −149.9 | 0.21 |
| FOS SRX070879 | HUVEC Cardiovascular | 499 / 19217 (2.6%) | 13487 / 192170 (7.0%) | −151.8 | −149.9 | 0.37 |
| FOXA1 SRX13814018 | 5637 Others | 291 / 19217 (1.5%) | 10112 / 192170 (5.3%) | −151.7 | −149.8 | 0.29 |
| FOXA1 SRX3931055 | MCF-7 Breast | 404 / 19217 (2.1%) | 11976 / 192170 (6.2%) | −151.4 | −149.5 | 0.34 |
| ARID1A SRX5089388 | MCF-7 Breast | 233 / 19217 (1.2%) | 9081 / 192170 (4.7%) | −151.3 | −149.4 | 0.26 |
| GATAD2A SRX2636507 | Hep G2 Liver | 500 / 19217 (2.6%) | 13482 / 192170 (7.0%) | −151.3 | −149.4 | 0.37 |
| HMG20A SRX2630163 | Hep G2 Liver | 262 / 19217 (1.4%) | 9592 / 192170 (5.0%) | −151.2 | −149.3 | 0.27 |
| ESR1 SRX9719167 | MCF-7 Breast | 202 / 19217 (1.1%) | 8505 / 192170 (4.4%) | −151.1 | −149.2 | 0.24 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 664 / 19217 (3.5%) | 15931 / 192170 (8.3%) | −151.0 | −149.2 | 0.42 |
| SMAD3 SRX366168 | NCI-H441 Lung | 412 / 19217 (2.1%) | 12093 / 192170 (6.3%) | −151.0 | −149.2 | 0.34 |
| FOXA1 SRX15430999 | T-47D Breast | 524 / 19217 (2.7%) | 13838 / 192170 (7.2%) | −151.0 | −149.1 | 0.38 |
| VGLL1 SRX18013277 | FULVR Breast | 195 / 19217 (1.0%) | 8366 / 192170 (4.4%) | −150.9 | −149.0 | 0.23 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 568 / 19217 (3.0%) | 1298 / 192170 (0.7%) | −150.8 | −148.9 | 4.38 |
| TET2 SRX8617001 | MCF-7 Breast | 308 / 19217 (1.6%) | 10367 / 192170 (5.4%) | −150.7 | −148.8 | 0.30 |
| ESR1 SRX10365534 | MCF-7 Breast | 134 / 19217 (0.7%) | 7165 / 192170 (3.7%) | −150.5 | −148.6 | 0.19 |
| GATA3 SRX100559 | T-47D Breast | 515 / 19217 (2.7%) | 13679 / 192170 (7.1%) | −150.4 | −148.5 | 0.38 |
| ESR1 SRX1012631 | MCF-7 Breast | 202 / 19217 (1.1%) | 8483 / 192170 (4.4%) | −150.4 | −148.5 | 0.24 |
| NKX2-1 SRX2164786 | A549 Lung | 782 / 19217 (4.1%) | 17592 / 192170 (9.2%) | −150.1 | −148.2 | 0.44 |
| ASPSCR1 SRX17321274 | ASPS1 Lung | 783 / 19217 (4.1%) | 17580 / 192170 (9.1%) | −149.4 | −147.5 | 0.45 |
| CDK9 SRX7366781 | MCF-7 Breast | 245 / 19217 (1.3%) | 150 / 192170 (0.1%) | −149.4 | −147.5 | 16.33 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 149 / 19217 (0.8%) | 7432 / 192170 (3.9%) | −149.3 | −147.4 | 0.20 |
| JUNB SRX10119385 | MCF 10A Breast | 211 / 19217 (1.1%) | 8614 / 192170 (4.5%) | −149.3 | −147.4 | 0.24 |
| JUND SRX699738 | HCASMC Cardiovascular | 668 / 19217 (3.5%) | 15919 / 192170 (8.3%) | −149.2 | −147.3 | 0.42 |
| FOSL2 SRX10475315 | Hep G2 Liver | 516 / 19217 (2.7%) | 13647 / 192170 (7.1%) | −149.1 | −147.2 | 0.38 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 897 / 19217 (4.7%) | 19162 / 192170 (10.0%) | −149.0 | −147.1 | 0.47 |
| FOSL2 SRX10475316 | Hep G2 Liver | 624 / 19217 (3.2%) | 15264 / 192170 (7.9%) | −148.9 | −147.0 | 0.41 |
| NR3C1 SRX10977357 | A549 Lung | 291 / 19217 (1.5%) | 10017 / 192170 (5.2%) | −148.9 | −147.0 | 0.29 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 857 / 19217 (4.5%) | 2802 / 192170 (1.5%) | −148.6 | −146.7 | 3.06 |
| HDAC2 SRX190281 | MCF-7 Breast | 412 / 19217 (2.1%) | 12004 / 192170 (6.2%) | −148.5 | −146.6 | 0.34 |
| Epitope tags SRX2745846 | MCF 10A Breast | 303 / 19217 (1.6%) | 10206 / 192170 (5.3%) | −148.3 | −146.4 | 0.30 |
| FOXA1 SRX3923517 | MCF-7 Breast | 347 / 19217 (1.8%) | 10938 / 192170 (5.7%) | −148.3 | −146.4 | 0.32 |
| STAT5B SRX831881 | CD8+ T cells Blood | 250 / 19217 (1.3%) | 165 / 192170 (0.1%) | −148.0 | −146.1 | 15.15 |
| LEO1 SRX1873456 | SEM Blood | 1515 / 19217 (7.9%) | 6929 / 192170 (3.6%) | −148.0 | −146.1 | 2.19 |
| KMT2C SRX1787675 | MCF-7 Breast | 417 / 19217 (2.2%) | 12058 / 192170 (6.3%) | −147.8 | −145.9 | 0.35 |
| ING5 SRX286202 | RKO Digestive tract | 1359 / 19217 (7.1%) | 5891 / 192170 (3.1%) | −147.8 | −145.9 | 2.31 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 307 / 19217 (1.6%) | 10254 / 192170 (5.3%) | −147.8 | −145.9 | 0.30 |
| ESR1 SRX5323876 | MCF-7 Breast | 250 / 19217 (1.3%) | 9261 / 192170 (4.8%) | −147.5 | −145.6 | 0.27 |
| FOSL2 SRX190204 | A549 Lung | 471 / 19217 (2.5%) | 12895 / 192170 (6.7%) | −147.5 | −145.6 | 0.37 |
| ESR1 SRX4451214 | MCF-7 Breast | 416 / 19217 (2.2%) | 12021 / 192170 (6.3%) | −147.3 | −145.4 | 0.35 |
| FOS SRX150664 | HUVEC Cardiovascular | 630 / 19217 (3.3%) | 15286 / 192170 (8.0%) | −147.2 | −145.3 | 0.41 |
| NFIC SRX190336 | SK-N-SH Neural | 662 / 19217 (3.4%) | 15747 / 192170 (8.2%) | −147.1 | −145.2 | 0.42 |
| SMC1A SRX1013333 | HuCCT1 Liver | 901 / 19217 (4.7%) | 19138 / 192170 (10.0%) | −147.0 | −145.2 | 0.47 |
| FOXA1 SRX1161203 | T-47D Breast | 345 / 19217 (1.8%) | 10859 / 192170 (5.7%) | −146.9 | −145.1 | 0.32 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 343 / 19217 (1.8%) | 10822 / 192170 (5.6%) | −146.7 | −144.8 | 0.32 |
| FOXA1 SRX3923518 | MCF-7 Breast | 338 / 19217 (1.8%) | 10737 / 192170 (5.6%) | −146.7 | −144.8 | 0.31 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 174 / 19217 (0.9%) | 7835 / 192170 (4.1%) | −146.4 | −144.6 | 0.22 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 675 / 19217 (3.5%) | 15909 / 192170 (8.3%) | −146.4 | −144.5 | 0.42 |
| FOXA1 SRX5203294 | MCF-7 Breast | 136 / 19217 (0.7%) | 7085 / 192170 (3.7%) | −146.4 | −144.5 | 0.19 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 460 / 19217 (2.4%) | 12671 / 192170 (6.6%) | −146.0 | −144.2 | 0.36 |
| ESR1 SRX3123823 | MCF-7 Breast | 164 / 19217 (0.9%) | 7626 / 192170 (4.0%) | −145.9 | −144.0 | 0.22 |
| ESR1 SRX5089450 | MCF-7 Breast | 255 / 19217 (1.3%) | 9294 / 192170 (4.8%) | −145.8 | −144.0 | 0.27 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 474 / 19217 (2.5%) | 12878 / 192170 (6.7%) | −145.8 | −144.0 | 0.37 |
| ESR1 SRX5089447 | MCF-7 Breast | 217 / 19217 (1.1%) | 8610 / 192170 (4.5%) | −145.6 | −143.8 | 0.25 |
| RNF2 SRX18954704 | FaDu Others | 1107 / 19217 (5.8%) | 21874 / 192170 (11.4%) | −145.6 | −143.7 | 0.51 |
| STAT3 SRX5323860 | MCF-7 Breast | 600 / 19217 (3.1%) | 14780 / 192170 (7.7%) | −145.6 | −143.7 | 0.41 |
| FOXA1 SRX5203307 | MCF-7 Breast | 138 / 19217 (0.7%) | 7103 / 192170 (3.7%) | −145.5 | −143.6 | 0.19 |
| TCF21 DRX190655 | HCF Cardiovascular | 787 / 19217 (4.1%) | 17458 / 192170 (9.1%) | −145.0 | −143.1 | 0.45 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 804 / 19217 (4.2%) | 2556 / 192170 (1.3%) | −144.9 | −143.1 | 3.15 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 574 / 19217 (3.0%) | 14361 / 192170 (7.5%) | −144.7 | −142.9 | 0.40 |
| NR3C1 SRX10977372 | A549 Lung | 280 / 19217 (1.5%) | 9688 / 192170 (5.0%) | −144.6 | −142.8 | 0.29 |
| SP1 SRX5457499 | Liver Liver | 818 / 19217 (4.3%) | 17877 / 192170 (9.3%) | −144.6 | −142.8 | 0.46 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 346 / 19217 (1.8%) | 10790 / 192170 (5.6%) | −144.3 | −142.5 | 0.32 |
| NANOG SRX10445309 | Neural crest cells Neural | 264 / 19217 (1.4%) | 9400 / 192170 (4.9%) | −144.3 | −142.4 | 0.28 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 567 / 19217 (3.0%) | 14235 / 192170 (7.4%) | −144.2 | −142.4 | 0.40 |
| RXRB SRX2636027 | Hep G2 Liver | 517 / 19217 (2.7%) | 13480 / 192170 (7.0%) | −144.2 | −142.4 | 0.38 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 354 / 19217 (1.8%) | 10913 / 192170 (5.7%) | −144.2 | −142.3 | 0.32 |
| SOX5 SRX2636544 | Hep G2 Liver | 481 / 19217 (2.5%) | 12914 / 192170 (6.7%) | −143.8 | −141.9 | 0.37 |
| Epitope tags SRX20741925 | Hep G2 Liver | 819 / 19217 (4.3%) | 17854 / 192170 (9.3%) | −143.7 | −141.9 | 0.46 |
| ESR1 SRX968963 | MCF-7 Breast | 192 / 19217 (1.0%) | 8084 / 192170 (4.2%) | −143.6 | −141.7 | 0.24 |
| ARID1A SRX5679787 | 12Z Others | 183 / 19217 (1.0%) | 7917 / 192170 (4.1%) | −143.5 | −141.7 | 0.23 |
| SOX6 SRX10475370 | Hep G2 Liver | 841 / 19217 (4.4%) | 18150 / 192170 (9.4%) | −143.4 | −141.6 | 0.46 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 202 / 19217 (1.1%) | 8268 / 192170 (4.3%) | −143.4 | −141.6 | 0.24 |
| FOXA1 SRX1161172 | MCF-7 Breast | 487 / 19217 (2.5%) | 12989 / 192170 (6.8%) | −143.3 | −141.5 | 0.37 |
| ESR1 SRX792933 | LY2 Breast | 403 / 19217 (2.1%) | 11673 / 192170 (6.1%) | −143.2 | −141.4 | 0.35 |
| FOXA1 SRX5323845 | MCF-7 Breast | 179 / 19217 (0.9%) | 7828 / 192170 (4.1%) | −143.1 | −141.3 | 0.23 |
| FOXA1 SRX3923519 | MCF-7 Breast | 309 / 19217 (1.6%) | 10117 / 192170 (5.3%) | −142.7 | −140.9 | 0.31 |
| FOXL2 SRX6957477 | KGN Gonad | 508 / 19217 (2.6%) | 13274 / 192170 (6.9%) | −142.3 | −140.5 | 0.38 |
| ZNF219 SRX3230413 | Hep G2 Liver | 821 / 19217 (4.3%) | 17821 / 192170 (9.3%) | −142.2 | −140.4 | 0.46 |
| 8-Hydroxydeoxyguanosine SRX13840522 | MCF 10A Breast | 1287 / 19217 (6.7%) | 5535 / 192170 (2.9%) | −141.9 | −140.1 | 2.33 |
| ESR1 SRX20282967 | MCF-7 Breast | 143 / 19217 (0.7%) | 7091 / 192170 (3.7%) | −141.7 | −139.8 | 0.20 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 187 / 19217 (1.0%) | 7929 / 192170 (4.1%) | −141.4 | −139.6 | 0.24 |
| TLE3 SRX4815193 | SUM 149PT Breast | 495 / 19217 (2.6%) | 13040 / 192170 (6.8%) | −141.3 | −139.5 | 0.38 |
| FOXA1 SRX190181 | A549 Lung | 358 / 19217 (1.9%) | 10875 / 192170 (5.7%) | −141.1 | −139.3 | 0.33 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 578 / 19217 (3.0%) | 14278 / 192170 (7.4%) | −141.1 | −139.2 | 0.40 |
| FOXA1 SRX5323830 | T-47D Breast | 296 / 19217 (1.5%) | 9844 / 192170 (5.1%) | −141.0 | −139.1 | 0.30 |
| TEAD1 SRX716558 | SF268 Neural | 243 / 19217 (1.3%) | 8928 / 192170 (4.6%) | −140.9 | −139.1 | 0.27 |
| SMARCA4 SRX5075168 | Neural progenitor cells Neural | 678 / 19217 (3.5%) | 15737 / 192170 (8.2%) | −140.9 | −139.0 | 0.43 |
| MYC SRX150570 | MCF 10A Breast | 334 / 19217 (1.7%) | 10470 / 192170 (5.4%) | −140.9 | −139.0 | 0.32 |
| FOXA1 SRX1961158 | T-47D Breast | 487 / 19217 (2.5%) | 12893 / 192170 (6.7%) | −140.7 | −138.9 | 0.38 |
Showing first 500 of 19725 rows.